Amarin
Dublin, Ireland· Est. 1989
Leading a new paradigm in cardiovascular care and growing our impact for patients globally
Private Company
Total funding raised: $197M
About
Leading a new paradigm in cardiovascular care and growing our impact for patients globally
Small Molecules
Funding History
4Total raised:$197M
PIPE$100MDec 15, 2019
IPO$62MJun 30, 2005
Series B$25MJun 15, 2001
Series A$10MJun 15, 1999